Post-Myocardial Infarction Bleeding Risk Examined

Risk of hospital admission for bleeding increases with number of antithrombotic drugs
By Jeff Muise
HealthDay Reporter

MONDAY, Dec. 14 (HealthDay News) -- For patients receiving antithrombotic drugs post heart attack, the risk of hospitalization for bleeding increases as the number of drugs increases, according to a study in the Dec. 12 issue of The Lancet.

Rikke Sorensen, M.D., of Copenhagen University Hospital Gentofte in Denmark, and colleagues analyzed 40,812 patients hospitalized with a first-time myocardial infarction between 2000 and 2005. The subjects were grouped by their prescribed antithrombotic drugs: monotherapy with aspirin, clopidogrel, or vitamin K antagonist; dual therapy with aspirin plus clopidogrel, aspirin plus vitamin K antagonist, or clopidogrel plus vitamin K antagonist; or triple therapy including all three. The researchers assessed the risk of hospital admission for bleeding and other outcomes for each regimen.

The researchers found the incidence of yearly bleeding for the medications to be as follows: aspirin, 2.6 percent; clopidogrel, 4.6 percent; vitamin K antagonist, 4.3 percent; aspirin plus clopidogrel, 3.7 percent; aspirin plus vitamin K antagonist, 5.1 percent; clopidogrel plus vitamin K antagonist, 12.3 percent; and triple therapy, 12 percent. Using aspirin as the referent, the hazard ratios for bleeding for the medications were: clopidogrel, 1.33; vitamin K antagonist, 1.23; aspirin plus clopidogrel, 1.47; aspirin plus vitamin K antagonist, 1.84; clopidogrel plus vitamin K antagonist, 3.52; and for triple therapy, 4.05.

"In patients with myocardial infarction, risk of hospital admission for bleeding increased with the number of antithrombotic drugs used. Treatment with triple therapy or dual therapy with clopidogrel plus vitamin K antagonist should be prescribed only after thorough individual risk assessment," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95


Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95


Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95


More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events